AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 285: R99-R109, 2003. First published March 6, 2003; doi:10.1152/ajpregu.00609.2002
0363-6119/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/R99    most recent
00609.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, H.
Right arrow Articles by Krueger, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, H.
Right arrow Articles by Krueger, J. M.

COMPLEX FUNCTIONS OF THE CENTRAL NERVOUS SYSTEM, SLEEP AND LOCOMOTION

A cyclooxygenase-2 inhibitor attenuates spontaneous and TNF-{alpha}-induced non-rapid eye movement sleep in rabbits

Hitoshi Yoshida, Takeshi Kubota, and James M. Krueger

Department of Veterinary, Comparative Anatomy, Pharmacology and Physiology, College of Veterinary Medicine, Washington State University, Pullman, Washington 99164-6520

Submitted 3 October 2002 ; accepted in final form 5 March 2003

Sleep is regulated in part by the brain cytokine network, including tumor necrosis factor-{alpha} (TNF-{alpha}). TNF-{alpha} activates the transcription factor nuclear factor-{kappa}B, which in turn promotes transcription of many genes, including cyclooxygenase-2 (COX-2). COX-2 is in the brain and is an enzyme responsible for production of prostaglandin D2. The hypothesis that central COX-2 plays a role in the regulation of spontaneous and TNF-{alpha}-induced sleep was investigated. Three doses (0.5, 5, and 50 µg) of NS-398, a highly selective COX-2 inhibitor, were injected intracerebroventricularly. The highest dose decreased non-rapid eye movement sleep. The intermediate and highest doses decreased electroencephalographic slow-wave activity; the greatest reduction occurred after 50 µg of NS-398 during the first 3-h postinjection period. Rapid eye movement sleep and brain temperature were not altered by any dose of NS-398. Pretreatment of rabbits with 5 or 50 µg of NS-398 blocked the TNF-{alpha}-induced increases in non-rapid eye movement sleep, electroencephalographic slow-wave activity, and brain temperature. These data suggest that COX-2 is involved in the regulation of spontaneous and TNF-{alpha}-induced sleep.

electroencephalogram; cytokine; slow-wave activity



Address for reprint requests and other correspondence: J. M. Krueger, Dept. of VCAPP, PO Box 646520, Washington State University, Pullman, WA 99164-6520 (E-mail: krueger{at}vetmed.wsu.edu).




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
T.C.B. Schutz, M.L. Andersen, and S. Tufik
Effects of COX-2 Inhibitor in Temporomandibular Joint Acute Inflammation
J. Dent. Res., May 1, 2007; 86(5): 475 - 479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.